Elkridge-based Cel-Sci expands clinical trial sites

Cel-Sci Corp., of Vienna, Va., and Elkridge, said its Taiwanese clinical trial partner, Orient Europharma, has added additional sites in Taiwan in Cel-Sci’s Phase III head and neck cancer clinical trial for Multikine, the company’s flagship investigational immunotherapy.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>


Scroll To Top